[Correspondence] Obesity, blood pressure, and cardiovascular outcomes
We read with interest the results of the subanalysis of the ACCOMPLISH trial (Feb 16, p 537), in which the effect of body mass on outcomes differed between the two major therapies tested (benazepril and amlodipine vs benazepril and hydrochlorothiazide).
Source: LANCET - Category: Journals (General) Authors: Fernando Elijovich, Cheryl Laffer Tags: Correspondence Source Type: research
More News: Benazepril | Cardiology | Cardiovascular | Eating Disorders & Weight Management | General Medicine | Heart | Hydrochlorothiazide | Lotrel | Norvasc | Obesity